Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 12/2020

01-12-2020 | Cancer Immunotherapy | Editorial

Carrying the torch & facing new challenges

Author: Haidong Dong

Published in: Cancer Immunology, Immunotherapy | Issue 12/2020

Login to get access

Excerpt

More than 60 years ago, while the field of cancer immunology was in its advent searching for a novel therapy for cancer, Dr. Georges Mathé, the founding editor of Cancer Immunology, Immunotherapy (CIIM), performed the world´s first successful allogeneic bone marrow transplant (1958), which he considered to be a form of cancer therapy and sparked a light in the dark for researchers. Years later in 1972, he lit the torch in the form of a specialist journal of CIIM, a title that perfectly reflected his foresight for the potential impact of immunotherapy in cancer treatment now widely accepted and practiced 40 years later. …
Metadata
Title
Carrying the torch & facing new challenges
Author
Haidong Dong
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Cancer Immunology, Immunotherapy / Issue 12/2020
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-020-02772-9

Other articles of this Issue 12/2020

Cancer Immunology, Immunotherapy 12/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine